We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+28.05%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$5.25B
Cap. Flow
+$4.62B
Cap. Flow %
45%
Top 10 Hldgs %
41.75%
Holding
2,600
New
918
Increased
493
Reduced
472
Closed
701

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$353M
2
MSFT icon
Microsoft
MSFT
+$352M
3
AAPL icon
Apple
AAPL
+$256M
4
BABA icon
Alibaba
BABA
+$189M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$125M

Sector Composition

Rank Sector Weight
1 Technology 14.28%
2 Consumer Discretionary 10.77%
3 Healthcare 5.09%
4 Industrials 4.03%
5 Financials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNS icon
2001
Cadence Design Systems
CDNS
$87.9B
-32,773
Closed -$3.5M
CF icon
2002
CF Industries
CF
$19.6B
-47,886
Closed -$1.47M
CHE icon
2003
Chemed
CHE
$7.07B
-719
Closed -$345K
CHRS icon
2004
Coherus Oncology
CHRS
$219M
-13,345
Closed -$245K
CHWY icon
2005
Chewy
CHWY
$9.83B
-9,747
Closed -$534K
CIEN icon
2006
Ciena
CIEN
$56B
-25,028
Closed -$993K
CIO
2007
DELISTED
City Office REIT
CIO
-13,707
Closed -$103K
CLBK icon
2008
Columbia Financial
CLBK
$1.23B
-73,453
Closed -$815K
CMBM
2009
DELISTED
Cambium Networks
CMBM
-11,839
Closed -$200K
CMCSA icon
2010
Comcast
CMCSA
$95.3B
-83,768
Closed -$4.01M
CME icon
2011
CME Group
CME
$98.9B
-9,302
Closed -$1.56M
CMI icon
2012
Cummins
CMI
$80.9B
-2,753
Closed -$581K
CNA icon
2013
CNA Financial
CNA
$13.3B
-14,445
Closed -$433K
CNO icon
2014
CNO Financial Group
CNO
$4.95B
-39,764
Closed -$638K
CNOB icon
2015
Center Bancorp
CNOB
$1.62B
-43,160
Closed -$607K
CODX
2016
CALL
Co-Diagnostics
CODX
$7.57M
-1,667
Closed -$680K
COF icon
2017
Capital One
COF
$134B
-5,146
Closed -$370K
VISN
2018
Vistance Networks Inc
VISN
$2.59B
-83,070
Closed -$748K
CP icon
2019
Canadian Pacific Kansas City
CP
$85B
-5,795
Closed -$353K
CPA icon
2020
Copa Holdings
CPA
$5.88B
-25,354
Closed -$1.28M
CPB icon
2021
Campbell Soup
CPB
$7.14B
-211,006
Closed -$10.2M
CPRT icon
2022
Copart
CPRT
$31.3B
-86,860
Closed -$2.28M
CPRI icon
2023
Capri Holdings
CPRI
$1.55B
-49,092
Closed -$884K
CRSR icon
2024
Corsair Gaming
CRSR
$1.18B
-122,969
Closed -$2.47M
CSIQ icon
2025
Canadian Solar
CSIQ
$988M
-58,050
Closed -$2.04M

Similar funds

Michael Gelband's Q4 2020 Portfolio in Review

As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.

  • Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
  • Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
  • Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
  • Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
  • Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
  • Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
  • Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.